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Abstract
The majority of studies on the effect of nanomaterials on biological function involves either
isolated in vitro cell systems or are concerned with in vivo effects after inhalational or dermal
exposure. The present work reports on an intriguing observation of the vascular effects seen in an
ex vivo perfused tissue preparation, the isolated perfused porcine skin flap (IPPSF), in studies
conducted to assess nanomaterial biodistribution. Compared to a relatively large dataset involving
organic chemical infusions (n=53), infusion of six different nanoparticles of diverse sizes and
composition (silica or dextran coated Fe2O3, silica or citrate coated silver, PEG or carboxylated
quantum dots (QD)) resulted in statistically significant post-infusion flap weight gain and an
increase in arterial perfusion pressure (especially with QD-PEG). In contrast, infusion with nC60
nanoparticles did not produce these effects. These observations suggest certain nanoparticle
infusions may be associated with acute vascular physiological effects which merit further
attention.
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Background
A wide variety of engineered nanomaterials have been developed and explored for their
application to varied disciplines. Safety has been a major concern affecting widespread
adoption. Although there have been a number of in vivo inhalational and in vitro cellular
toxicity studies (see Monteiro-Riviere and Tran, 2007 for comprehensive review), there is a
paucity of work defining the physiological effects after systemic exposure secondary to
injection for drug therapeutics or diagnostic applications or inadvertently post-absorption
after inhalational, topical or oral exposure. There are limited studies specifically looking at
the vascular effects of systemic nanomaterials of any composition.1,2,3
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Our laboratory developed an isolated perfused porcine skin flap (IPPSF) as an ex vivo
model primarily to study dermal drug and chemical absorption and cytotoxicity.4,5 This
model has also been used to study drug distribution after intra-arterial infusion,6 vascular
effects of autonomic drugs7 and more recently to model nanomaterial biodistribution after
intra-arterial infusion.2,8 In all experiments, data on arterial vascular resistance throughout
the infusion and skin flap weight prior to and following infusions have been collected on
some 3600 experiments. During recent studies involving intra-arterial infusion of various
nanomaterials, we noticed that compared with organic chemical experiments, infusion of
nanoparticles resulted in an increase in skin flap weight at the termination of an experiment
and vascular resistance that tended to be greater than with studies involving organic small
molecule infusions. These findings, although observational in nature, indicate a significant
biological interaction is occurring whose mechanism and relevance to in vivo effects should
be further explored in vivo.
Methods
The IPPSF is a single-pedicle, axial pattern tubed skin flap obtained from the abdomen of
female weanling Yorkshire pigs (Sus scrofa). Two flaps per animal, each lateral to the
ventral midline, are created in a single surgical procedure. The procurement, care and use of
animals were in accordance with the regulations and terms of the federal Animal Welfare
Act and North Carolina State University’s Institutional Animal Care and Use Committee
guidelines. The procedure involves surgical creation of the flap with skin measuring 4
cm×12 cm and perfused primarily by the caudal superficial epigastric artery and its
associated paired venae comitantes, followed by arterial cannulation and harvest in 48 hrs.
The IPPSF is then transferred to a perfusion apparatus that is a custom designed temperature
and humidity regulated chamber. Perfusion media consists of a modified Krebs-Ringer
bicarbonate buffer spiked with dextrose and bovine serum albumin. Normal perfusate flow-
rate is maintained at 1 ml/min/flap (3–7 ml/min/100g) with a mean arterial pressure ranging
from 30–70 mmHg, targets consistent with in vivo values reported in the literature. Viability
for up to 24 hr has been confirmed through biochemical studies and extensive light and
transmission electron microscopy studies. These techniques are fully described in the
literature.4,5
Nanomaterials (sources listed in Table 1) study compounds are mixed into the arterial
perfusate and concentrations measured in arterial and venous samples for biodistribution
studies. These particles were characterized by transmission electron microscopy, dynamic
light scattering (DLS) and Zeta potential and are listed in Table 1. A sample of organic
chemical infusion flaps (n=53) previously conducted in our laboratory were selected for
comparison. For the endpoints measured in the current work, skin flaps are weighed pre and
post infusion and the weight change plotted. Perfusion pressure as an estimate of vascular
resistance was measured in the arterial input line using an in-line pressure meter.
A one way analysis of variance was used to determine if the differences in the weight gain
among the types of infusions was significant (p<.05). A Dunnett’s multiple comparison post
hoc test was used to determine which nanoparticle infusion flaps were significantly different
from the organic chemical infusions (p<0.05). The mean and standard deviation of all
perfusions for each type of nanoparticle were determined for each measured time point and
plotted versus time to compare with the pressure during organic chemical perfusions. All
statistical analysis and plots were generated with prism GraphPad (GraphPad Software, Inc.,
La Jolla, CA).
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The change in flap weight (mean ± standard deviation) prior to and following the infusion
experiments for each type of nanoparticle, compared with the chemical infusions, is shown
in Figure 1. All nanoparticles except nC60 resulted in significantly greater changes in the
flap weight than have been observed previously with the organic chemical infusions.
However, as seen in Figure 2, several of the nanoparticles appeared to result in an increase
in pressure during the washout phase, only the infusions with the QD-PEG nanoparticles
was elevated higher than the range of values observed for the organic chemical perfusions.
These studies imply that intra-arterial infusion of some nanoparticles result in modulating
the vascular function as evidenced by changes in arterial pressure and skin flap weight gain
well beyond control or drug infusion studies.7 Increase in skin flap weight post infusion
would be a marker of congestion and edema formation due to processes occurring at
multiple sites in the flap vascular system. Praetner and co-workers1 specifically associated
anionic quantum dot association with capillary endothelium in in vivo mouse studies.
Previously, we have shown capillary endothelium uptake of quantum dots in IPPSF studies
which also demonstrated periodicity in arterial-venous extraction.2 A number of in vitro
endothelial cell studies and in vivo experiments have also hinted at nanoparticle effects on
the vascular system.9,10,11
The present studies were not designed to probe the mechanism of these vascular effects but
rather were an observation of abnormal vascular changes associated with nanoparticle
studies conducted primarily for pharmacokinetic and biodistribution endpoints. Potential
causes for such effects could be direct interaction of nanoparticles with vascular endothelial
cell or agglomeration and precipitation in capillary beds resulting in an increase in vascular
resistance and congestive edema, or local nanoparticle tissue deposition increasing osmotic
pressure also resulting in skin flap weight gain post infusion. However, based on two
decades of experimental data in this perfused tissue preparation, such effects are extra-
ordinary and deserving of notation and further studies in other in vivo models. They also
support the hint of cardiovascular toxicity seen with some nanomaterials and suggest this
endpoint should be evaluated when in vivo toxicology studies are conducted.
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Comparison of the weight gains of skin flaps among types of IPPSF experiments. The
weight gain varied significantly among infusion types (ANOVA, p<0.05) and all but nC60
differed significantly (p<0.05) from the organic chemical infusions (*).
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Arterial pressure (mean ± standard deviation) versus time during both the 4-hr exposure and
4-hr washout phase for the various nanoparticles and organic chemicals.
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